IL2 and neoplasm: Cytokines offer the opportunity to be combined with radiation or low dose chemotherapy as recently shown for IL-2 and IL-12 (49) with the rationale to induce local tumor cell apoptosis/necrosis and exposing tumor antigens to become targets for cytokine activated lymphocytes.